Iridex Corporation announced the US launch of its next-generation platform Iridex 532 and Iridex 577 Lasers alongside its 35th anniversary celebration. The announcement was made ahead of their official showcase at the Hawaiian Eye and Retina 2024 Meeting from January 13-19, 2024. Both lasers harness multiple treatment modes including continuous-wave and Iridex' patented MicroPulse Technology and an intuitive touchscreen interface providing a wide range of clinical control options and features to optimize the treatment of retinal disorders and glaucoma.

Product Highlights: Comprehensive Treatment Reports: Physicians can create detailed reports of treatment parameters for every procedure. These reports can be easily managed and downloaded to a USB drive. Configurable Preset Filters: Customizable filters, allowing for simple program management and selection via the new preset management tool enabling customizable selections by procedure and by individual doctor.

Enhanced User Experience: The multi-functional single control knob ensures simplified console navigation. Additionally, the 7" high-resolution touchscreen display offers an interactive experience, allowing physicians to navigate seamlessly between options. MicroPulse Laser Applications: MicroPulse, a laser delivery modality that adds fine control of photothermal effects in laser photocoagulation, is a tissue-sparing solution for the treatment of retinal diseases and glaucoma.